Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 25.93 USD -2.15%
Market Cap: $147.4B

Operating Margin

29.1%
Current
Improving
by 0.8%
vs 3-y average of 28.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
29.1%
=
Operating Income
$18.3B
/
Revenue
$62.8B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
29.1%
=
Operating Income
$18.3B
/
Revenue
$62.8B

Peer Comparison

Country Company Market Cap Operating
Margin
US
Pfizer Inc
NYSE:PFE
147.8B USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.4B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
388.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.9B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...
UK
GSK plc
XETRA:GS71
84.1B EUR
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...

Market Distribution

Higher than 89% of companies in the United States of America
Percentile
89th
Based on 14 112 companies
89th percentile
29.1%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Pfizer Inc
Glance View

Pfizer Inc., a name synonymous with pharmaceutical innovation, embarked on its journey in 1849 when German immigrants Charles Pfizer and Charles Erhart founded the company in Brooklyn, New York. Over the decades, the modest chemical business transformed into a titan of the pharmaceutical industry, delivering breakthroughs that have shaped modern medicine. The company operates through its robust engine of research and development, continually investing billions into discovering and bringing to market medications that address unmet medical needs. Spanning therapeutic areas such as oncology, vaccines, rare diseases, and cardiovascular and metabolic health, Pfizer's strategic focus ensures a diverse product pipeline that aligns with global health trends and challenges. The company's revenue model is predominantly driven by the development, marketing, and sale of its pharmaceutical products. Blockbuster drugs like Lipitor and recently, the COVID-19 vaccine developed in collaboration with BioNTech, have contributed significantly to its earnings. Pfizer's ability to maintain a strong balance between branded pharmaceuticals and generics allows it to effectively cater to both emerging markets and developed economies, while its strategic partnerships and acquisitions further bolster its reach and capabilities. The synergy of science and business acumen at Pfizer has made it not only a hub of medical innovation but also a formidable enterprise in the competitive landscape of healthcare.

PFE Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
29.1%
=
Operating Income
$18.3B
/
Revenue
$62.8B
What is Pfizer Inc's current Operating Margin?

The current Operating Margin for Pfizer Inc is 29.1%, which is above its 3-year median of 28.3%.

How has Operating Margin changed over time?

Over the last 3 years, Pfizer Inc’s Operating Margin has decreased from 39.9% to 29.1%. During this period, it reached a low of 19.4% on Mar 31, 2024 and a high of 40.3% on Dec 31, 2022.

Back to Top